A study on ALDH6A1 as a potential biomarker of hepatocellular carcinoma showed that an increase in ALDH6A1 in ALDH6A1-O/E cells would cause a reduction in NAD+/NADH, which consequently disrupts mitochondrial membrane potential. Here, ALDH6A1 is linked to hepatocellular carcinoma.